<p>Advanced technological holding company Quantum X Labs Inc. (Nasdaq: QXL) has announced the launch of an integrated quantum software development program. The dual-pronged initiative pairs the company’s proprietary clinical trial data analysis algorithm—the core mathematical foundation of its Clini